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1. Introductiou 
Hb Hope 0136 (H 14) Gly --f Asp was found initially 
by Minnich et al. in 1965 [l] in an American Negro 
family. He published the structure and described Hb 
Hope as a clinically silent hemoglobin. The function 
was not studied. Peru& in 1968 [2] proposed as a 
hypothesis, the formation of a new salt bridge between 
Asp 136 and Val Nr of the Hb Hope fl chain. This 
paper describes the functional properties of a new case 
of Hb Hope found in a propositus native of the Mali 
Republic. This study shows a decreased oxygen affinity, 
a decreased cooperativity, a normal Bohr effect and a 
decreased DPG effect. Molecular interpretation of these 
abnormalities is discussed and Hb Hope properties are 
compared with those of others hemoglobins presenting 
a modified DPG effect. 
2. Materials and methods 
The propositus was a 25 year old Negro native of 
Mali, hospitalized after an episod of articular inflamma- 
tion of his knee followed by abdominal pains. 
Hematologic studies were performed according to 
standard methods. 
2.1. Identification of the mutation 
The abnormal hemoglobin was isolated by column 
North-Hol~nd ~b~ishing Company - Amsterdam 
chromatography on amberlite Biorex 70 in a 0,04 M 
phosphate buffer pH 7.12 [3] without cyanide. 
Localization of the abnormal peptide was obtained 
by fingerprints on silica gel [4] . Structural analysis of 
the abnormal peptide was performed after its isolation 
and puri~cation on ion exchange column chromato- 
graphy. 251. 
2.2. Determination of functional properties 
Oxygen equilibrium curves were determined on red 
blood cells and on hemoglobin solutions by the 
spectrophotometric method of Benesch 161. Oxygen 
equilibria of isolated Hb A and Hb Hope were deter- 
mined using hemoglobins stripped by chromatography 
on Sephadex G 25 171. Equilibrium curves of the red 
blood cells were measured at 37’C in 0.15 M phosphate 
buffers at pH ranging from 6.45 to 7.45; the curves 
of stripped hemoglobins were measured in 0.05 M 
bis-Tris or 0.05 M Tris buffers according to the pH 
values. PsO of Hb A and Hb Hope were determined in 
presence of varying amounts of 2,3-dipl~osphoglycerate 
(DPG) from Benesch’s technique [S] modified using 
0.05 M Tris buffer at pH 7.15. Increasing amounts of 
DPG were introduced into the tonometer before each 
determination. The cy~lohexylammonium salt of DPG 
(Calbiochem) was used after conversion to the free acid 
form [9] and titration to neutrality. Amounts of methe 
moglobin were measured before and after each 
determination according to Benesch [lo] . 
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The binding of DPG to hemoglobin was measured 
with an ultrafiltration technique using cellulose nitrate 
membranes in a high pressure apparatus [ 111. The 
binding experiments were carried out at pH 7.2 in bis- 
Tris buffer 50 mM 0.1 M Cl-, on deoxyhemoglobin 
at a concentration of free DPG of approximately 
5 X lo-’ M. Hemoglobin concentration was 5 X lo-’ 
M on a tetramer basis, temperature was 22’C. The DPG 
concentrations in the Hb-DPG mixture and in the 
ultrafiltrate were determined by the enzymatic method 
of Rose [12]. 
3. Results 
Clinical and hematologic findings demonstrated 
only the presence of a slight anemia. The Coultronic 
S furnished the following values: Hb 12- 13 g%, RBC 
4.3 X 106, PCV: 36.5, MCV: 86 fi3, MCH: 28, MCHC 
33%. Reticulocyte count was 55 000, WBC count was 
6000/mm3. Total blood volume was 3400 ml (normal: 
3500 ml), packed red cell volume: 1180 ml (normal: 
1400), plasmatic volume: 2200 ml (normal: 2000). 
This anemia was isolated, without hemolytic symptoms, 
enlargement of the spleen, or anti red cells ~tibodies. 
OD 570 nm 
1 
This anemia with a decreased red cell mass is probably 
due to a slight decrease of the bone marrow activity. 
Electrophoresis of hemoglobin on cellulose acetate 
strips at pH 8.6 demonstrated the presence of an 
abnormal hemoglobin representing approximately 
40% of the total 
3.1. Structural studies 
Results of(i) electrophoresis of hemoglobin and its 
chains, (ii) fingerprints of the S-aminoethylated p chain 
were identical to those obtained by Minnich. We have 
used a distinct method for isolating abnormal peptide. 
Elution profil of chromatography of the tryptic 
hydrolysate S-AE /3 chain is presented in fig. 1 which 
shows the position of the mutated peptide where 
amino acid analysis demonstrated replacement of the 
136 Gly by an aspartic acid. 
3.2. Oxygen equilibrium curves 
Results of oxygen equilibrium curves of the intact 
red blood cells from the patient are presented in fig. 2. 
At the pH tested, the patient’s curves are shifted to the 
right of the normal curves at the corresponding pH. 
Pso (partial pressure of oxygen at 50% Hb 02) at pH 
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Fig. 1. Elution profiles of chromato~aphy of the tryptic digest of normal and abnormal aminoethy~ated p chains on PA 3.5 
(Beckman) exchange ion resin. From top to bottom chains PA and p Hope. Hatched zones indicate the positions of the pT14-15 
peptides, the arrows show the normal position of the pT14 peptide. 
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Fig. 2. Oxygen dissociation curves determined at 37°C on red cells suspension from the patient containing 60% of Hb A and 40% 
of Hb Hope at pH 6.45 (-•-a----), pH 7.15 (-m-m-) and pH 7.45 (-A-A---A) and from control normal red 
cells at pH 7.15 (-o--o-). On the right side of the figure Hill’s plot of the data obtained at pH 7.15 from the control 
(--O-c---) and from the patient red cells (-¤.--.-). 
October 1974 
respectively (normal values 52 + 2, 30 f 1 and 22 + 
1 mmHg). These shifts could not be explained by the 
normal range of the DPG level : 15 PM/~ Hb. Hill plot 
representation produced no evidence of biphasic curve. 
The results of the oxygen equilibrium curves of 
isolated Hb Hope and Hb A are represented in fig. 3. 
They show that Hb Hope has a lowered oxygen 
affinity, with a preserved alkaline Bohr effect (fig. 4). 
The Hill’s coefficient was found to be 2.2 (normal 
2.8), indicating a decreased cooperativity. 
/+I ,I/ 
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Fig. 3. Oxygen equilibria curves of purified and stripped 
1 / 
/,’ 
hemoglobin A and hemoglobin Hope. (-a-a-n-), 
Hb A at pH 7.45; (-o----o-), Hb A at pH 7.15; 
(-o-o-o-), Hb A at pH 6.45; (-A-A-A-), 
20 40 80 8'0 Hb Hope at pH 7.45; (-¤---m-w----), Hb Hope at pH 
0, PRESSURE mm Hg 7.15; (-•-w--•----), Hb Hope at pH 6.45. 
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Fig. 4. The pH dependence of the oxygen equilibrium of 
hemoglobins Hope (-¤.--•---_) and Hb A (-o---o--_). 
The ‘n’ range value (-A-A---) is (2.3-2.0) for Hb Hope 
and (2.6-3.1) for Hb A (--A--a--_). 
3.3. Effect of DPG on Hb Hope 
The Pso of stripped Hb A and Hb Hope were then 
measured after addition of increasing amounts of DPG. 
The amounts of methemoglobin A and Hope were 
found to be 1.5% at the beginning of these experiments 
and never exceeded 3.5% at the end of them. Results 
of variations of PsO according to the level of DPG are 
represented in fig. 5. In our findings the maximum effect 
of DPG added to Hb A was obtained with a DPG/Hb 
A molar ratio of 20, the displacement of PsO being of 
27 mmHg..In contrast amounts of DPG required for 
giving the plateau with Hb Hope were twice those 
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Fig. 5. Action of increasing amounts of DPG on P,, of Hb Hope (-¤--¤---_) and Hb A (---•-----_). The P,, obtained 
at 37°C in Tris-HCl 0.05 M pH 7.15 are plotted as a function of themratio. 
Hb 
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necessitated for Hb A. These results indicate that the 
reaction of Hb Hope with DPG is abnormal. To find 
the causes of this abnormal reaction we have measured 
the DPG/deoxyhemoglobin Hope dissociation constant. 
This was done by a direct method using the ultrafiltra- 
tion technic. The apparent dissociation constant K’ 
was found to be 12 X 10e5 M for Hb Hope. In the 
same experimental conditions K’ was found to be 
1.5 X 10v5 M for normal Hb A. 
Thus the abnormal reaction of DPG with Hb Hope 
is mostly due to a low affinity of this ligand for Hb 
Hope. 
4. Discussion 
Hb Hope is a new case of hemoglobin with a 
decreased oxygen affinity. This functional modification 
is found in the absence of methemo~obinisation as in 
Hb M Iwate [ 131 or M Boston [14] and also, in the 
absence of instability as in Hb Seattle [ 15 ,161, 
Hammersmith [ 171, Torino [ 181, Bristol [ 191, Tacoma 
[20], Bucuresti 1211 and Okaloosa 1221. 
Numerous cases of abnormal hemoglobins with 
high oxygen affinity have been described but only 5 
cases of abnormal hemoglobins with isolated low O2 
af~nity are known: Agenogi [23] , Kansas 1241, 
Yoshizuka [25 J , Peterborough [26] and Hope. These 
hemoglobins lead to a decreased red blood cell volume. 
The mechanisms implicated may concern the degree of 
stimulation of synthesis of erythropoietic [27]. 
To explain the structure function relationship of 
these low O2 affinity hemoglobins, two major distinct 
types of mechanisms have been evocated [28] : (i) the 
mutation modifies the conformation of the heme 
pocket, thus inhibiting the entrance of the O2 mole- 
cule: this is the case, for example, of Hb H~mersmith 
and of Hb Bristol; (ii) the substitution favorizes the 
deoxystate by a purely stereochemical effect as in 
the case of Hb Peterborough /3 (G 13) Val + Phe where 
the substitution is included in the cam/?, contact area 
and where the new Phe can be accomodated only in 
the deoxy form. 
An other example is Hb Agenogi fi (F6) Glu + Lys 
where the lysine probably interacts with the C terminal 
residue of the p chain, maintaining the HC2 tyrosine 
in its pocket. 
The mechanism hypothesized for Hb Hope is 
different. We assume that the salt bridge binding Asp 
/3 H14 with the QI amino group of Val p NAt can 
maintain the p chain in a tight conformation ‘t’ which 
displaces towards the left the deoxy + oxy equilibrium. 
Absence of modi~cation of the Bohr effect signifies 
that residues implicated in this effect are not involved 
by the mutation. 
In addition, the abnormal bond between H14 and 
NI can also explain the abnormal reaction between Mb 
Hope and DPG. In Hb Hope, DPG fixation in the 
central cavity is partially inhibited since NA1 which 
normally is involved in an ionic bond with DPG is 
blocked-Hb Hope is a new case of Hb with a mutation 
involving the central cavity and giving rise to a 
decreased DPG effect. In all the previously described 
cases: Hb Bethesda [29], Hb Sheperds Bush [30], Hb 
L&den [31] [32] and Hb Little Rock [33], the low 
observed DPG effect was associated with a high oxygen 
affinity. The opposite effect is observed with Hb 
Hope. Interpretation of this discrepancy can afford 
new elements in the stereochemical mechanisms 
involved in the Hb ligand binding. 
Moreover in this work, we have used two distinct 
approaches to estimate the DPG effect on Hb Hope. 
Results obtained by the two technics are very similar. 
The direct measurement of dissociation constant DPG/ 
deoxyhemo~obin by the ultra~ltration method has 
been applied for the first time in this work to an 
abnormal hemoglobin. Its use seemed to us to be 
generalized because it is a very fast technic and mostly 
because it affords more precise information on the 
impairment of DPG effect. 
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